A modified protein appears to trigger lung fibrosis after environmental exposure
The triggers and causes of a severe scarring disease of the lungs—idiopathic pulmonary fibrosis, or IPF—remain unclear.
Mar 18, 2021
0
102
The triggers and causes of a severe scarring disease of the lungs—idiopathic pulmonary fibrosis, or IPF—remain unclear.
Mar 18, 2021
0
102
Researchers at the University of Alabama at Birmingham have identified a new molecular target that could potentially treat the deadly, aging-related lung disease idiopathic pulmonary fibrosis (IPF). The study, which will ...
Mar 10, 2021
0
3
New research could shed light on the mystery cause of a lung disease that is a major killer, and potentially unlock new treatments.
Dec 08, 2020
0
10
A multi-channel recording device developed at TU Graz for pathological lung sounds and associated automatic lung sound analysis could support existing screening methods for early detection of, for example, COVID-19 infections. ...
Dec 07, 2020
0
0
A new treatment option for lung fibrosis is being developed by Purdue University scientists. Lung fibrosis has been a concern for COVID-19 patients.
Nov 11, 2020
0
3
Autoimmune disease is fundamentally a mystery: whyever should an organism systematically set out to harm itself? Now, researchers at the University of Tsukuba have identified a genetic basis for anti-neutrophil cytoplasmic ...
Nov 04, 2020
0
2
Your lungs and airways need to be stretchy, sort of like balloons. Take a big breath, and they'll open right up.
Sep 24, 2020
0
28
Idiopathic pulmonary fibrosis is a potentially lethal disease for which there is currently no cure and that is associated with certain mutations or advanced age. The Telomeres and Telomerase Group at the Spanish National ...
Aug 10, 2020
0
3
A pre-clinical study led by scientists at Cincinnati Children's demonstrates that in mice the drug barasertib reverses the activation of fibroblasts that cause dangerous scar tissue to build up in the lungs of people with ...
Aug 06, 2020
0
6
More than 30 years after the last guidance on the clinical evaluation of hypersensitivity pneumonitis (HP), the American Thoracic Society—in collaboration with the Asociación Latinoamericana de Tórax or ALAT and the Japanese ...
Aug 03, 2020
0
1